ESMO-ASCO: THE EVOLUTION OF THE CLINICAL TRIAL LANDSCAPE

Can collaborative molecular screening platforms (CMSPs) support new forms of cancer clinical research? The example of the EORTC SPECTA programme

D. Lacombe